Drug Type Autologous CAR-T |
Synonyms- |
Target |
Mechanism CD123 inhibitors(Interleukin-3 receptor subunit alpha inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 1/2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Leukemia | Phase 2 | CN | 01 Oct 2016 | |
Myeloid Tumor | Phase 2 | CN | 01 Oct 2016 |